The excess of carriers in rare disorders suggests a nonpathogenic effect for most variants of uncertain significance

Mostra el registre complet Registre parcial de l'ítem

• dc.contributor.author Medaglia, Stefano
• dc.contributor.author Reig-Palou, Jaume
• dc.contributor.author Bellés, Ariadna
• dc.contributor.author Moreno Ruiz, Nerea
• dc.contributor.author Rodríguez, Jairo
• dc.contributor.author Armengol, Xavier
• dc.contributor.author Aróstegui Gorospe, Juan Ignacio
• dc.contributor.author Armengol i Dulcet, Lluís
• dc.contributor.author Guillén, Juan José
• dc.contributor.author Laayouni, Hafid, 1968-
• dc.contributor.author Casals López, Ferran
• dc.date.accessioned 2025-01-24T15:44:43Z
• dc.date.available 2025-01-24T15:44:43Z
• dc.date.issued 2024
• dc.description Data de publicació electrònica: 05-11-2024
• dc.description.abstract Functional annotation and interpretation of genetic variants are a critical step in genetic diagnosis, as it may lead to personalized therapeutic options and genetic counseling. While the number of confirmed pathogenic genetic variants in an individual is relatively low, the number of variants of uncertain significance (VOUS) can be considerably higher, increasing the number of potential carriers of genetic disorders. Thus, reducing uncertainty and assessing the real effect of VOUS are crucial for clinical and medical genetics. In this study, we evaluated the efficacy of genetic screening technologies in accurately predicting pathogenic variants and their corresponding disease prevalence in a cohort of over 6000 healthy individuals involved in assisted reproduction programs. Using data from 305 genes associated with recessive disorders, we determined the frequency of carriers of pathogenic variants and VOUS in our dataset and compared the predicted prevalence based on this information with reported population prevalence data. The higher predicted prevalence in some disorders when considering VOUS suggests a mostly benign effect.
• dc.format.mimetype application/pdf
• dc.identifier.citation Medaglia S, Reig-Palou J, Bellés A, Moreno-Ruiz N, Rodríguez J, Armengol X, et al. The excess of carriers in rare disorders suggests a nonpathogenic effect for most variants of uncertain significance. Clin Genet. 2024 Nov 5. DOI: 10.1111/cge.14642
• dc.identifier.doi http://dx.doi.org/10.1111/cge.14642
• dc.identifier.issn 0009-9163
• dc.identifier.uri http://hdl.handle.net/10230/69270
• dc.language.iso eng
• dc.publisher Wiley
• dc.relation.ispartof Clin Genet. 2024 Nov 5
• dc.rights © 2024 The Author(s). Clinical Genetics published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
• dc.rights.accessRights info:eu-repo/semantics/openAccess
• dc.rights.uri http://creativecommons.org/licenses/by-nc/4.0/
• dc.subject.keyword VOUS
• dc.subject.keyword Carrier screening
• dc.subject.keyword Functional annotation
• dc.subject.keyword Recessive disorders
• dc.title The excess of carriers in rare disorders suggests a nonpathogenic effect for most variants of uncertain significance
• dc.type info:eu-repo/semantics/article
• dc.type.version info:eu-repo/semantics/publishedVersion